Monkeypox: what we know and what we need to learn

Event type: 
Event date: 
Monday, 22 August 2022 - 1:00pm to 2:30pm
Free - registrations are essential. Please register on the booking link below.
Contact for inquiries: 
Rata Joseph, +61 (2) 9385 0900 or
Booking deadline: 


Monkeypox (MPX) has arrived in Australia, and strategies are urgently needed to curb its spread. While Australia has secured some third-generation smallpox vaccine, supply issues mean urgent consideration is needed as to how the vaccine is best distributed. And with men who have sex with men currently the most at risk group for MPX, non-stigmatising and community-led prevention programs will be crucial. 

Please join us for a special webinar on MPX where we consider the history of the epidemic, how it may impact Australia, and how research can help. Collaborative, rigorous and timely research can uncover pragmatic solutions to the challenges posed by MPX, and there are many lessons that can be applied from the HIV and COVID-19 pandemics.

Professor Raina MacIntyre is on the WHO SAGE smallpox and MPX working group, and will give an overview of prevention and treatment of orthopoxviruses. Professor Andrew Grulich, a leader in Australia’s response to HIV, will provide a description of the current epidemic in Australia and the available public health responses. They will be joined by Mr Heath Paynter from AFAO who will talk about the community response to MPX in Australia.


Professor Raina MacIntyre  

Professor Raina MacIntyre
Head, Biosecurity Program, Kirby Institute

Raina MacIntyre (MBBS Hons 1, M App Epid, PhD, FRACP, FAFPHM) is Professor of Global Biosecurity, NHMRC Principal Research Fellow and Head of the Biosecurity Program at the Kirby Institute, UNSW, Australia. She leads a research program in control and prevention of infectious diseases, spanning vaccinology, pandemics and emerging infections, and personal protective equipment. Her area of vaccine expertise is vaccination of older adults and immunosuppressed people, as well as the role of influenza and other infections on triggering cardiovascular events, and how these can be prevented by vaccines.

Twitter: @Globalbiosec

Professor Andrew Grulich  

Professor Andrew Grulich
Head, HIV Epidemiology and Prevention Program, Kirby Institute

Andrew Grulich is an internationally renowned authority in the transmission and prevention of HIV and sexually transmissible infections (STIs) and in the epidemiological relationship between immune deficiency, infection and cancer.

Twitter: @AndrewGrulich

Mr Heath Paynter  

Mr Heath Paynter
Deputy Chief Executive Officer, Australian Federation of AIDS Organisations (AFAO)

Heath Paynter is the Deputy CEO of the Australian Federation of AIDS Organisations. Heath’s professional background includes more than thirteen years' experience working as a lawyer, and in public health policy providing advice on human rights and preventative health focusing on community health and systems strengthening cancer control, sexual health, HIV and other blood borne viruses. Through this work, he continually collaborates with community and consumer agencies to ensure the treatment and care needs of health care users are considered in decision making around access to new health technology.



Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.

Header image: Samuel F. Johanns from Pixabay